NASONEX NASAL SPRAY

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

MOMETASONE FUROATE 50 MCG/DOSE

Mevcut itibaren:

MERCK SHARP & DOHME ISRAEL LTD

ATC kodu:

D07AC13

Farmasötik formu:

SOLUTION

Uygulama yolu:

NASAL

Tarafından üretildi:

SCHERING-PLOUGH LAB.NV BELGIUM

Terapötik grubu:

MOMETASONE

Terapötik endikasyonlar:

In adults and children 3 years of age and older to treat the symptoms of seasonal or perennial rhinitis. In patients 12 years old and above who have a history of moderate to severe symptoms of seasonal allergic rhinitis prophylactic treatment with Nasonex Aqueous Nasal Spary is recommended 2- 4 weeks prior to the anticipated start of the pollen season.

Yetkilendirme tarihi:

2013-03-01